Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

359 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Is the "Habsburg jaw" related to inbreeding?
Vilas R, Ceballos FC, Al-Soufi L, González-García R, Moreno C, Moreno M, Villanueva L, Ruiz L, Mateos J, González D, Ruiz J, Cinza A, Monje F, Álvarez G. Vilas R, et al. Among authors: villanueva l. Ann Hum Biol. 2019 Dec;46(7-8):553-561. doi: 10.1080/03014460.2019.1687752. Epub 2019 Dec 2. Ann Hum Biol. 2019. PMID: 31786955
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Chang YH, Lee JL, Sarwar N, Haas NB, Gurney H, Sawrycki P, Mahave M, Gross-Goupil M, Zhang T, Burke JM, Doshi G, Melichar B, Kopyltsov E, Alva A, Oudard S, Topart D, Hammers H, Kitamura H, McDermott DF, Silva A, Winquist E, Cornell J, Elfiky A, Burgents JE, Perini RF, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2024 Apr 18;390(15):1359-1371. doi: 10.1056/NEJMoa2312695. N Engl J Med. 2024. PMID: 38631003 Clinical Trial.
Photostrictive Actuators Based on Freestanding Ferroelectric Membranes.
Ganguly S, Pesquera D, Garcia DM, Saeed U, Mirzamohammadi N, Santiso J, Padilla J, Roque JMC, Laulhé C, Berenguer F, Villanueva LG, Catalan G. Ganguly S, et al. Among authors: villanueva lg. Adv Mater. 2024 Mar 28:e2310198. doi: 10.1002/adma.202310198. Online ahead of print. Adv Mater. 2024. PMID: 38546029
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.
Llovet JM, Kudo M, Merle P, Meyer T, Qin S, Ikeda M, Xu R, Edeline J, Ryoo BY, Ren Z, Masi G, Kwiatkowski M, Lim HY, Kim JH, Breder V, Kumada H, Cheng AL, Galle PR, Kaneko S, Wang A, Mody K, Dutcus C, Dubrovsky L, Siegel AB, Finn RS; LEAP-002 Investigators. Llovet JM, et al. Lancet Oncol. 2023 Dec;24(12):1399-1410. doi: 10.1016/S1470-2045(23)00469-2. Lancet Oncol. 2023. PMID: 38039993 Clinical Trial.
359 results